Perspectives of application of intranasally administered insulin for correction of metabolic and hormonal disorders in diabetes mellitus and metabolic syndrome

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


In recent years, the possibility of using intranasally administered insulin to treat Alzheimer's disease and other cognitive disorders has been widely studied. At the same time, the possibility of its use in the treatment of diabetes mellitus is practically not investigated, which is due to the insufficient study of the molecular mechanisms of its action on the hormonal and metabolic status of the organism. The review discusses literature data and the results of our own research on the role of insulin in the central regulation of energy homeostasis, as well as on the experience of using intranasally administered insulin to correct eating disorders and metabolic and hormonal dysfunctions developing under conditions of experimental diabetes mellitus and metabolic syndrome. In studies involving healthy volunteers, various effects of intranasally administered insulin were shown, including effects on cognitive function, eating behavior and weight loss, and the gender specificity of its action was found. In the course of numerous studies of intranasally administered insulin in animal models of diabetes mellitus, not only stabilization of carbohydrate homeostasis was shown, but also a positive effect in the form of restoration of the functional activity of insulin signaling pathways in the hypothalamus and other parts of the brain. We have presented and analyzed data on the systemic effects of intranasally administered insulin in rodents with experimental models of diabetes mellitus, as well as in healthy individuals.

About the authors

Alexander Olegovich Shpakov

Sechenov Institute of evolutionary physiology and biochemistry Russian academy of sciences

ORCID iD: 0000-0002-4293-3162
SPIN-code: 6335-8311
Scopus Author ID: 35231150500

Doctor Biological Sciences, Deputy director for science

Russian Federation, 194223 Russia, Saint-Petersburg, pr. Torez 44

Kira Viktorovna Derkach

Sechenov Institute of evolutionary physiology and biochemistry Russian academy of sciences

ORCID iD: 0000-0001-6555-9540
SPIN-code: 6925-1558
Scopus Author ID: 6603743572

Candidate of Biological Sciences, Deputy Director on General issues

Russian Federation, 194223 Russia, Saint-Petersburg, pr. Torez 44

Elena Victorovna Surkova

Endocrinology Research Centre

ORCID iD: 0000-0002-3973-7638
SPIN-code: 7944-3869
Scopus Author ID: 6602194740

Doctor of Medical Sciences, Chief Researcher

Russian Federation, 117036, Moscow, St. Dmitry Ulyanov, 11

Alexey Igorevich Bespalov

Endocrinology Research Centre

Author for correspondence.
ORCID iD: 0000-0003-1584-5690
SPIN-code: 9466-2528

Аспирант отдела прогнозирования и инноваций диабета

Russian Federation, 117036, Moscow, St. Dmitry Ulyanov, 11


  1. Шпаков А. О., Деркач К. В.: Гормональные системы мозга и сахарный диабет 2-го типа. - Изд-во Политехн. ун-та. – 2015. – Т. 252. [Shpakov A. O., Derkach K. V. Gormonal'nye sistemy mozga i saharnyj diabet 2-go tipa. - Izd-vo Politekhn. un-ta. – 2015. – T. 252. (in Russ)]
  2. Gizurarson S, Bechgaard E. Intranasal administration of insulin to humans. Diabetes Research and Clinical Practice. 1991;12(2):71-84. doi: 10.1016/0168-8227(91)90083-p.
  3. Hirai S, Ikenaga T, Matsuzawa T. Nasal Absorption of Insulin in Dogs. Diabetes. 1978;27(3):296-299. doi: 10.2337/diab.27.3.296.
  4. Frauman A, Buchanan R, Jerumus G, Louis W. Intranasal insulin (INI) treatment of type I diabetes: clinical and immunologic effects using two different absorption enhancing adjuvants. Diabetes Res. Clin. Pract.. 1988;5(Suppl. 1):S162.
  5. Деркач КВ, Иванцов АО, Чистякова ОВ, Сухов ИБ, Бузанаков ДМ, Куликова АА, Шпаков АО. Лечение крыс с метаболическим синдромом интраназальным инсулином восстанавливает метаболические показатели и чувствительность к инсулину. Бюллетень экспериментальной биологии и медицины. 2017;163(2):144-9. [Derkach K.V., Ivantsov A.O., Chistyakova O.V., Sukhov I.B., Buzanakov D.M., Kulikova A.A., Shpakov A.O. Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome. Bulletin of Experimental Biology and Medicine. 2017. Т. 163. № 2. С. 184-189. (in Russ)]
  6. Craft S. Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment. Archives of Neurology. 2012;69(1):29. doi: 10.1001/archneurol.2011.233.
  7. Baskin D. Insulin In The Brain. Annual Review of Physiology. 1987;49(1):335-347. doi: 10.1146/annurev.physiol.49.1.335.
  8. Porte Jr D, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia. 1998 Jul 1;41(8):863-81. doi: 10.1007/s001250051
  9. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine. 2002;8(12):1376-1382. doi: 10.1038/nm1202-798.
  10. Hallschmid M, Benedict C, Schultes B, Fehm H-L, Born J, Kern W. Intranasal Insulin Reduces Body Fat in Men but not in Women. Diabetes. 2004;53(11):3024-3029. doi: 10.2337/diabetes.53.11.3024.
  11. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL. Sniffing neuropeptides: a transnasal approach to the human brain. Nature neuroscience. 2002 Jun;5(6):514. doi: 10.1038/nn0602-849
  12. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003 Mar 1;52(3):682-7. doi: 10.2337/diabetes.52.3.682
  13. Hallschmid M, Benedict C, Schultes B, Born J, Kern W. Obese men respond to cognitive but not to catabolic brain insulin signaling. International journal of obesity. 2008 Feb;32(2):275. doi: 10.1038/sj.ijo.0803722
  14. Jauch-Chara K, Friedrich A, Rezmer M, et al. Intranasal Insulin Suppresses Food Intake via Enhancement of Brain Energy Levels in Humans. Diabetes. 2012;61(9):2261-2268. doi: 10.2337/db12-0025.
  15. Kenny PJ. Reward mechanisms in obesity: new insights and future directions. Neuron. 2011 Feb 24;69(4):664-79. doi: 10.1016/j.neuron.2011.02.016
  16. Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends in cognitive sciences. 2011 Jan 1;15(1):37-46. doi: 10.1016/j.tics.2010.11.001
  17. Appelhans BM. Neurobehavioral inhibition of reward‐driven feeding: implications for dieting and obesity. Obesity. 2009 Apr 1;17(4):640-7. doi: 10.1038/oby.2008.638
  18. Lathe R. Hormones and the hippocampus. Journal of Endocrinology. 2001 May 1;169(2):205-31.doi: 10.1677/joe.0.1690205
  19. Figlewicz DP, Szot P, Chavez M, Woods SC, Veith RC. Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain research. 1994 May 2;644(2):331-4.doi: 10.1016/0006-8993(94)91698-5
  20. Guthoff M, Grichisch Y, Canova C, Tschritter O, Veit R, Hallschmid M, Häring HU, Preissl H, Hennige AM, Fritsche A. Insulin modulates food-related activity in the central nervous system. The Journal of Clinical Endocrinology & Metabolism. 2010 Feb 1;95(2):748-55. doi: 10.1210/jc.2009-1677
  21. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 2006 Apr 1;55(4):978-87. doi: 10.2337/diabetes.55.04.06.db05-1339
  22. Krug R, Benedict C, Born J, Hallschmid M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. The Journal of Clinical Endocrinology & Metabolism. 2010 Dec 1;95(12):E468-72. doi: 10.1210/jc.2010-0744
  23. Hallschmid M, Higgs S, Thienel M, Ott V, Lehnert H. Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. Diabetes. 2012 Apr 1;61(4):782-9.doi: 10.2337/db11-1390
  24. Koch L, Wunderlich FT, Seibler J, Könner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Brüning JC. Central insulin action regulates peripheral glucose and fat metabolism in mice. The Journal of clinical investigation. 2008 Jun 2;118(6):2132-47.doi: 10.1172/JCI31073
  25. Heni M, Wagner R, Kullmann S, Veit R, Husin HM, Linder K, Benkendorff C, Peter A, Stefan N, Häring HU, Preissl H. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014 Dec 1;63(12):4083-8.doi: 10.2337/db14-0477
  26. Dash S, Xiao C, Morgantini C, Koulajian K, Lewis GF. Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations. Diabetes. 2015 Mar 1;64(3):766-74.doi: 10.2337/db14-0685
  27. Chen M, Woods SC, Porte D. Effect of cerebral intraventricular insulin on pancreatic insulin secretion in the dog. Diabetes. 1975 Oct 1;24(10):910-4.doi: 10.2337/diab.24.10.910
  28. Filippi BM, Yang CS, Tang C, Lam TK. Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell metabolism. 2012 Oct 3;16(4):500-10. doi: 10.1016/j.cmet.2012.09.005
  29. Chaiken RL, Moses AC, Silver RD, Elahi D, Minaker K, Rowe J, Flier J. The Prolonged Hypoglycemic Effect Of An Insulin-Adjuvant Nasal Spray In Diabetes Is Secondary To Prolonged Suppression Of Hepatic Glucose Output. Inclinical Research 1985 Jan 1 (Vol. 33, No. 2, Pp. A426-A426). 6900 Grove Rd, Thorofare, Nj 08086: Slack Inc.
  30. Шпаков А.О., Мойсеюк И.В., Чистякова О.В., Деркач К.В., Сухов И.Б., Бондарева В.М. Лечение интраназальным инсулином и серотонином восстанавливает чувствительность аденилатциклазы к гормонам в мозге крыс с длительным неонатальным диабетом. Бюллетень ФЦСКЭ им. ВА Алмазова. 2013 Feb(1):21-7. [Shpakov A.O., Moiseyuk I.V., Chistyakova O.V., Derkach K.V., Sukhov I.B., Bondareva V.M. Treatment with intranasal insulin and serotonin restores the sensitivity of adenylyl cyclase to hormone in the brain of rats with long-term neonatal diabetes mellitus. Byulleten' FTsSKE im. VA Almazova. 2013 Feb(1):21-7. (in Russ)]
  31. Shpakov A, Chistyakova O, Derkach K, Moyseyuk I, Bondareva V. Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes. Open Life Sciences. 2012;7(1). doi: 10.2478/s11535-011-0089-6.
  32. Шпаков А.О., Деркач К.В., Чистякова О.В., Мойсеюк И.В., Сухов И.Б., Бондарева В.М. Влияние интраназального инсулина и серотонина на функциональную активность аденилатциклазной системы в миокарде, яичниках и матке крыс с пролонгированной неонатальной моделью сахарного диабета. Журнал эволюционной биохимии и физиологии. – 2013. – Т. 49. – №. 2. – С. 118-127. [Shpakov AO, Derkach KV, Chistyakova OV, Moiseyuk IV, Sukhov IB, Bondareva VM. Effect of intranasal insulin and serotonin on functional activity of the adenylyl cyclase system in myocardium, ovary, and uterus of rats with prolonged neonatal model of diabetes mellitus. Journal of Evolutionary Biochemistry and Physiology. 2013;49(2):153-164. doi: 10.1134/s0022093013020047. (in Russ)]
  33. Сухов И.Б., Деркач К.В., Чистякова О.В., Бондарева В.М., Шпаков А.О. Функциональное состояние гипоталамических сигнальных систем у крыс с сахарным диабетом 2-го типа, леченных интраназальным инсулином. Журнал эволюционной биохимии и физиологии. – 2016. – Т. 52. – №. 3. – С. 184-194. [Sukhov IB, Derkach KV, Chistyakova OV, Bondareva VM, Shpakov AO. Erratum: “Functional state of hypothalamic signaling systems in rats with type 2 diabetes mellitus treated with intranasal insulin.” Journal of Evolutionary Biochemistry and Physiology. 2016;52(5):426-426. doi: 10.1134/s1234567816050141. (in Russ)]
  34. Кузнецова Л.А., Плеснева С.А., Шарова Т.С., Перцева М.Н., Шпаков А.О. Ослабление ингибирующего влияния гормонов на аденилатциклазную систему в миокарде и мозге крыс с ожирением и сахарным диабетом 2-го типа и действие на него интраназального инсулина. Журнал эволюционной биохимии и физиологии. – 2014. – Т. 50. – №. 5. – С. 349-357. [Kuznetsova LA, Plesneva SA, Sharova TS, Pertseva MN, Shpakov AO. Attenuation of inhibitory influence of hormones on adenylyl cyclase systems in the myocardium and brain of obese and type 2 diabetic rats as affected by the intranasal insulin treatment. Journal of Evolutionary Biochemistry and Physiology. 2014;50(5):399-408. doi: 10.1134/s0022093014050044..(in Russ)]
  35. Кузнецова Л.А., Шарова Т.С., Перцева М.Н., Шпаков А.О. Бета-адренергическая регуляция аденилатциклазной системы в миокарде и мозге крыс с ожирением и сахарным диабетом 2-го типа и влияние на нее длительной обработки с помощью интраназально вводимого инсулина. Журнал эволюционной биохимии и физиологии. – 2015. – Т. 51. – №. 3. – С. 170-180 [Kuznetsova LA, Sharova TS, Pertseva MN, Shpakov AO. Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration. Journal of Evolutionary Biochemistry and Physiology. 2015;51(3):198-209. doi: 10.1134/s0022093015030040. (in Russ)]
  36. Шпаков А.О., Чистякова О.В., Деркач К.В., Мойсеюк И.В., Бондарева В.М. Активность рецепторных гуанилатциклаз у крыс с неонатальным стрептозотоциновым диабетом и влияние на нее интраназального введения инсулина и серотонина. Цитология. – 2011. – Т. 53. – №. 7. – С. 591-599. [Shpakov AO, Chistyakova OV, Derkach KV, Moyseyuk IV, Bondareva VM. Activity of receptor guanylyl cyclases in rats with neonatal streptozotocin diabetes and effect of intranasal administration of insulin and serotonin. Cell and Tissue Biology. 2011;5(5):453-462. doi: 10.1134/s1990519x11050105. (in Russ)]
  37. Чистякова О.В., Сухов И.Б., Шипилов В.Н., Бондарева В.М., Шпаков А.О. Влияние интраназального введения инсулина и серотонина на когнитивные процессы у крыс с экспериментальным сахарным диабетом 2-го типа. Обзоры по клинической фармакологии и лекарственной терапии. – 2010. – Т. 8. – №. 1. [Chistyakova O. V., Sukhov I. B., Shipilov V. N., Bondareva V.M., Shpakov A.O. Vliyanie intranazal'nogo vvedeniya insulina i serotonina na kognitivnye protsessy u krys s eksperimental'nym sakharnym diabetom 2-go tipa. Obzory po klinicheskoi farmakologii i lekarstvennoi terapii. – 2010. – T. 8. – №. 1.(in Russ)]
  38. Кузнецова Л. А., Деркач К. В., Шарова Т. С., Бондарева В. М., Шпаков А. О. Активность NO-синтаз в мозге, миокарде и скелетных мышцах крыс с ожирением и влияние на нее длительного лечения интраназальным инсулином. Трансляционная медицина. – 2015. – №. 1. – С. 39-45. [Kuznetsova L.A., Derkach K.V., Sharova T.S., Bondareva V.M., Shpakov A.O. The activity of no-synthases in the brain, myocardium and skeletal muscles of obese rats and the influence of long-term treatment with intranasal insulin. Translyatsionnaya meditsina. – 2015. – №. 1. – S. 39-45 (in Russ)]
  39. Деркач К. В., Игнатьева П. А., Шпаков А. О. Гормональная регуляция аденилатциклазы в миокарде самцов крыс с метаболическим синдромом и влияние на нее лечения метформином и интраназально вводимым инсулином //Трансляционная медицина. – 2016. – Т. 3. – №. 1. – С. 73-81. [Derkach K. V., Ignat'eva P. A., Shpakov A. O. Hormonal regulation of adenylyl cyclase in the myocardium of male rats with metabolic syndrome and the influence of treatment with metformin and intranasally administered insulin. Translyatsionnaya meditsina. – 2016. – T. 3. – №. 1. – S. 73-81. (in Russ)]
  40. Деркач К.В., Иванцов А.О., Чистякова О.В. и др. Лечение крыс с метаболическим синдромом интраназальным инсулином восстанавливает метаболические показатели и чувствительность к инсулину. Бюллетень экспериментальной биологии и медицины. – 2017. – Т. 163. – №. 2. – С. 144-149. [Derkach KV, Ivantsov AO, Chistyakova OV, et al. Intranasal Insulin Restores Metabolic Parameters and Insulin Sensitivity in Rats with Metabolic Syndrome. Bulletin of Experimental Biology and Medicine. 2017;163(2):184-189. doi: 10.1007/s10517-017-3762-6. (in Russ)]
  41. Шпаков А. О. Функциональная активность инсулиновой сигнальной системы мозга в норме и при сахарном диабете 2-го типа //Российский физиологический журнал им. ИМ Сеченова. – 2015. – Т. 101. – №. 10. – С. 1103-1127. [Shpakov AO. Functional Activity of the Insulin Signaling System of the Brain in Health and Type 2 Diabetes Mellitus. Neuroscience and Behavioral Physiology. 2016;47(2):190-203. doi: 10.1007/s11055-016-0385-8. (in Russ)]
  42. Шпаков А. О., Деркач К. В. Молекулярные механизмы влияния метформина на функциональную активность нейронов мозга //Российский физиологический журнал им. ИМ Сеченова. – 2017. – Т. 103. – №. 5. – С. 504-517. [Shpakov AO, Derkach KV. The Melanocortin Signal System of the Hypothalamus and Its Functional State in Type 2 Diabetes Mellitus and Metabolic Syndrome. Neuroscience and Behavioral Physiology. 2017;47(5):495-507. doi: 10.1007/s11055-017-0426-y. (in Russ)]
  43. Сухов И.Б., Шипилов В.Н., Чистякова О.В., Трост А.М., Шпаков А.О. Длительное интраназальное введение инсулина улучшает пространственную память у крыс-самцов с пролонгированным сахарным диабетом 1-го типа и у здоровых крыс. Доклады Академии наук. – Федеральное государственное унитарное предприятие Академический научно-издательский, производственно-полиграфический и книгораспространительский центр Наука, 2013. – Т. 453. – №. 5. – С. 577-577. [Sukhov IB, Shipilov VN, Chistyakova OV, Trost AM, Shpakov AO. Long-term intranasal insulin administration improves spatial memory in male rats with prolonged type 1 diabetes mellitus and in healthy rats. Doklady Biological Sciences. 2013;453(1):349-352. doi: 10.1134/s001249661306015x. (in Russ)]
  44. Derkach K, Bogush I, Berstein L, Shpakov A. The Influence of Intranasal Insulin on Hypothalamic-Pituitary-Thyroid Axis in Normal and Diabetic Rats. Hormone and Metabolic Research. 2015;47(12):916-924. doi: 10.1055/s-0035-1547236.

Supplementary files

There are no supplementary files to display.



Abstract: 34


Copyright (c) 2021 Shpakov A.O., Derkach K.V., Surkova E.V., Bespalov A.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies